{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T10:58:12Z","timestamp":1788865092627,"version":"build-2803163510"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T00:00:00Z","timestamp":1656028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Malignant glioma is the most common solid tumor of the adult brain, with high lethality and poor prognosis. Hence, identifying novel and reliable biomarkers can be advantageous for diagnosing and treating glioma. Several galectins encoded by LGALS genes have recently been reported to participate in the development and progression of various tumors; however, their detailed role in glioma progression remains unclear. Herein, we analyzed the expression and survival curves of all LGALS across 2,217 patients with glioma using The Cancer Genome Atlas (TCGA), Chinese Glioma Genome Atlas (CGGA), and Rembrandt databases. By performing multivariate Cox analysis, we built a survival model containing <jats:italic>LGALS1<\/jats:italic>, <jats:italic>LGALS3<\/jats:italic>, <jats:italic>LGALS3BP<\/jats:italic>, <jats:italic>LGALS8<\/jats:italic>, and <jats:italic>LGALS9<\/jats:italic> using TCGA database. The prognostic power of this panel was assessed using CGGA and Rembrandt datasets. ESTIMATE and CIBERSORT algorithms confirmed that patients in high-risk groups exhibited significant stromal and immune cell infiltration, immunosuppression, mesenchymal subtype, and isocitrate dehydrogenase 1 (IDH1) wild type. Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), CancerSEA, and Gene Set Enrichment Analysis (GSEA) showed that pathways related to hypoxia, epithelial-to-mesenchymal transition (EMT), stemness, and inflammation were enriched in the high-risk group. To further elucidate the function of LGALS in glioma, we performed immunohistochemical staining of tissue microarrays (TMAs), Western blotting, and cell viability, sphere formation, and limiting dilution assays following lentiviral short hairpin RNA (shRNA)-mediated LGALS knockdown. We observed that LGALS expression was upregulated in gliomas at both protein and mRNA levels. LGALS could promote the stemness maintenance of glioma stem cells (GSCs) and positively correlate with M2-tumor-associated macrophages (TAMs) infiltration. In conclusion, we established a reliable survival model for patients with glioma based on LGALS expression and revealed the essential roles of LGALS genes in tumor growth, immunosuppression, stemness maintenance, pro-neural to mesenchymal transition, and hypoxia in glioma.<\/jats:p>","DOI":"10.3389\/fonc.2022.834307","type":"journal-article","created":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T07:27:41Z","timestamp":1656055661000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Prognostic Value and Biological Function of Galectins in Malignant Glioma"],"prefix":"10.3389","volume":"12","author":[{"given":"Hongtao","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingdian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailong","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suojun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingjiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3322\/caac.21613","article-title":"Management of Glioblastoma: State of the Art and Future Directions","volume":"70","author":"Tan","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJMoa1308573","article-title":"A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma","volume":"370","author":"Gilbert","year":"2014","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.16669","article-title":"Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial","volume":"314","author":"Stupp","year":"2015","journal-title":"JAMA"},{"key":"B4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/cells9030689","article-title":"The Galectin Family as Molecular Targets: Hopes for Defeating Pancreatic Cancer","volume":"9","author":"Manero-Ruperez","year":"2020","journal-title":"Cells"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/cwz077","article-title":"Galectin-8 in the Onset of the Immune Response and Inflammation","volume":"30","author":"Tribulatti","year":"2020","journal-title":"Glycobiology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-18-0638","article-title":"LGALS3 Promotes Treatment Resistance in Glioblastoma and Is Associated With Tumor Risk and Prognosis","volume":"28","author":"Wang","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1476-4598-11-32","article-title":"Galectin-1, a Gene Preferentially Expressed at the Tumor Margin, Promotes Glioblastoma Cell Invasion","volume":"11","author":"Toussaint","year":"2012","journal-title":"Mol Cancer"},{"key":"B8","first-page":"33","article-title":"Galectin-8 Promotes Migration and Proliferation and Prevents Apoptosis in U87 Glioblastoma Cells","volume-title":"Biol Res","author":"Metz","year":"2016"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32102","article-title":"Immunogenomic Analysis Reveals LGALS1 Contributes to the Immune Heterogeneity and Immunosuppression in Glioma","volume":"145","author":"Chen","year":"2019","journal-title":"Int J Cancer"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00182","article-title":"LGALS3 Is a Poor Prognostic Factor in Diffusely Infiltrating Gliomas and Is Closely Correlated With CD163+Tumor-Associated Macrophages","volume":"7","author":"Hu","year":"2020","journal-title":"Front Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0096801","article-title":"IHC Profiler: An Open Source Plugin for the Quantitative Evaluation and Automated Scoring of Immunohistochemistry Images of Human Tissue Samples","volume":"9","author":"Varghese","year":"2014","journal-title":"PLoS One"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1089\/omi.2011.0118","article-title":"Clusterprofiler: An R Package for Comparing Biological Themes Among Gene Clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/now247","article-title":"GlioVis Data Portal for Visualization and Analysis of Brain Tumor Expression Datasets","volume":"19","author":"Bowman","year":"2017","journal-title":"Neuro-Oncology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1","volume":"17","author":"Verhaak","year":"2010","journal-title":"Cancer Cell"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2006.02.019","article-title":"Molecular Subclasses of High-Grade Glioma Predict Prognosis, Delineate a Pattern of Disease Progression, and Resemble Stages in Neurogenesis","volume":"9","author":"Phillips","year":"2006","journal-title":"Cancer Cell"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring Tumour Purity and Stromal and Immune Cell Admixture From Expression Data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat Commun"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1126\/science.1254257","article-title":"Single-Cell RNA-Seq Highlights Intratumoral Heterogeneity in Primary Glioblastoma","volume":"344","author":"Patel","year":"2014","journal-title":"Science"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky939","article-title":"CancerSEA: A Cancer Single-Cell State Atlas","volume":"47","author":"Yuan","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.11920","article-title":"Galectin-3 Supports Stemness in Ovarian Cancer Stem Cells by Activation of the Notch1 Intracellular Domain","volume":"7","author":"Kang","year":"2016","journal-title":"Oncotarget"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.13860","article-title":"Galectin-3 Promotes CXCR2 to Augment the Stem-Like Property of Renal Cell Carcinoma","volume":"22","author":"Huang","year":"2018","journal-title":"J Cell Mol Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/cwv088","article-title":"Galectin-3 Modulates the EGFR Signalling-Mediated Regulation of Sox2 Expression via C-Myc in Lung Cancer","volume":"26","author":"Kuo","year":"2016","journal-title":"Glycobiology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.celrep.2017.03.059","article-title":"Hepatocellular Carcinomas Originate Predominantly From Hepatocytes and Benign Lesions From Hepatic Progenitor Cells","volume":"19","author":"Tummala","year":"2017","journal-title":"Cell Rep"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-18-0651","article-title":"Accumulation of Circulating CCR7(+) Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic Pathway","volume":"7","author":"Cristiani","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/ncb3090","article-title":"Periostin Secreted by Glioblastoma Stem Cells Recruits M2 Tumour-Associated Macrophages and Promotes Malignant Growth","volume":"17","author":"Zhou","year":"2015","journal-title":"Nat Cell Biol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151815","article-title":"Comparative Analysis of Matrix Metalloproteinase Family Members Reveals That MMP9 Predicts Survival and Response to Temozolomide in Patients With Primary Glioblastoma","volume":"11","author":"Li","year":"2016","journal-title":"PLoS One"},{"key":"B26","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/nature08712","article-title":"The Transcriptional Network for Mesenchymal Transformation of Brain Tumours","volume":"463","author":"Carro","year":"2010","journal-title":"Nature"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.168","article-title":"SUMOylation of PUM2 Promotes the Vasculogenic Mimicry of Glioma Cells via Regulating CEBPD","volume":"10","author":"Wang","year":"2020","journal-title":"Clin Trans Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13008-020-00061-6","article-title":"IGFBP5 Increases Cell Invasion and Inhibits Cell Proliferation by EMT and Akt Signaling Pathway in Glioblastoma Multiforme Cells","volume":"15","author":"Dong","year":"2020","journal-title":"Cell Div"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-018-0003-5","article-title":"Current State of Immunotherapy for Glioblastoma","volume":"15","author":"Lim","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2019.0353","article-title":"Neutrophil Extracellular Traps Mediate the Crosstalk Between Glioma Progression and the Tumor Microenvironment via the HMGB1\/RAGE\/IL-8 Axis","volume":"17","author":"Zha","year":"2020","journal-title":"Cancer Biol Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s11864-019-0619-4","article-title":"Current State of Immunotherapy for Treatment of Glioblastoma","volume":"20","author":"McGranahan","year":"2019","journal-title":"Curr Treat Options Oncol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/nn.4185","article-title":"The Role of Microglia and Macrophages in Glioma Maintenance and Progression","volume":"19","author":"Hambardzumyan","year":"2016","journal-title":"Nat Neurosci"},{"key":"B33","doi-asserted-by":"publisher","first-page":"7849890","DOI":"10.1155\/2016\/7849890","article-title":"Glioma Stem Cells: Signaling, Microenvironment, and Therapy","volume":"2016","author":"Liebelt","year":"2016","journal-title":"Stem Cells Int"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1101\/gad.261982.115","article-title":"Cancer Stem Cells in Glioblastoma","volume":"29","author":"Lathia","year":"2015","journal-title":"Genes Dev"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12102860","article-title":"The Role of Hypoxia and SRC Tyrosine Kinase in Glioblastoma Invasiveness and Radioresistance","volume":"12","author":"Torrisi","year":"2020","journal-title":"Cancers"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s11684-020-0760-2","article-title":"Intratumor Heterogeneity, Microenvironment, and Mechanisms of Drug Resistance in Glioma Recurrence and Evolution","volume":"15","author":"Bao","year":"2021","journal-title":"Front Med"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.834307\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T07:27:44Z","timestamp":1656055664000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.834307\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,24]]},"references-count":36,"alternative-id":["10.3389\/fonc.2022.834307"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.834307","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,24]]},"article-number":"834307"}}